Internet-Focused Promotion, Warning Letters Both Up As FDA Guidance Nears

As pharmaceutical companies await FDA guidance to help them navigate the pitfalls of Internet and social media promotion, firms are steadily increasing their participation on the Internet in general.

More from Archive

More from Pink Sheet